Skip to content

Clinical research on the development of patient exploration tools for patients suspected of Fabry disease in the medical checkup support app

Clinical research on the development of patient exploration tools for patients suspected of Fabry disease in the medical checkup support app - Clinical research on the development of patient exploration tools for patients suspected of Fabry disease in the medical checkup support app

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057036
Enrollment
10000
Registered
2025-03-01
Start date
2025-09-17
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who receive a health checkup after April 2025 at one facility at the medical examination center in Tokyo. Those who have registered for the CARADA medical check-up support app and are using their own smartphones to manage their health through medical check-up data Those who have the consent of providing their own data in the CARADA medical examination support app for participation in this clinical research and participation to the research institution

Exclusion criteria

Exclusion criteria: Those under 18 years old Those who are judged by the research responsibility or co-investigator to be inappropriate as a research subject for the research

Design outcomes

Primary

MeasureTime frame
The CARADA medical examination support app is a medical examination support app developed by MTI Co., Ltd. The conversion rate (transition rate, action rate) of subjects at each user touch point for the search tool set up in this app to detect suspected patients with Fabry disease will be evaluated as follows. 1.Participation rate (consent rate) of this clinical study among all patients referred to this clinical study 2.The following behaviors of study subjects who are judged to be suspected of having Fabry disease 2-1.Consultation rate at the consultation desk when screening results are reported 2-2.Appointment rate of specialist medical institutions after reporting screening results 3.Response rate of questionnaires conducted for all study subjects

Countries

Japan

Contacts

Public ContactHiroyuki Yamakawa

Keio University Hosital Center For Preventive Medicine

roroyama@gmail.com03-6910-3533

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026